Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 04 Jun 2020 English Publisher:WileyJournal:Cancer, volume 126, pages 3,624-3,626 (issn: 0008-543X, eissn: 1097-0142,

Copyright policy )

Authors: Stefano Cavalieri; Lisa Licitra;

doi: 10.1002/cncr.32971

pmid: 32497251

Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma

- Summary
- Subjects
- Metrics

Abstract

NPC‐0501 has shown that induction chemotherapy provides a survival benefit for patients with locoregionally advanced nasopharyngeal carcinoma and has added evidence to current knowledge. In the intensity‐modulated radiotherapy era, neoadjuvant chemotherapy should be considered at least for patients with high‐risk disease.

Related Organizations

University of Milan
Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Italy

Keywords

Epstein-Barr Virus Infections, Herpesvirus 4, Human, Nasopharyngeal Carcinoma, Humans, Nasopharyngeal Neoplasms, Induction Chemotherapy

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average